|
Re: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
9
|
Resverlogix Corp.
|
Oct 14, 2020 10:30PM
|
|
Re: ORI
|
7
|
Resverlogix Corp.
|
Oct 16, 2020 12:18PM
|
|
Re: The problem...as I see it
|
6
|
Resverlogix Corp.
|
Oct 16, 2020 05:02PM
|
|
Re: Total Shares Outstanding 10/15/20
|
2
|
Resverlogix Corp.
|
Oct 16, 2020 05:21PM
|
|
Re: The problem...as I see it
|
2
|
Resverlogix Corp.
|
Oct 16, 2020 08:25PM
|
|
Re: The problem...as I see it
|
1
|
Resverlogix Corp.
|
Oct 16, 2020 11:02PM
|
|
Re: The problem...as I see it cityslicker99
|
5
|
Resverlogix Corp.
|
Oct 17, 2020 05:36PM
|
|
Re: Re San fran
|
1
|
Resverlogix Corp.
|
Oct 20, 2020 04:24AM
|
|
Re: Re San fran
|
1
|
Resverlogix Corp.
|
Oct 20, 2020 04:31AM
|
|
Re: Re San fran
|
3
|
Resverlogix Corp.
|
Oct 20, 2020 04:52AM
|
|
Re: Covid and apabetalone
|
4
|
Resverlogix Corp.
|
Oct 21, 2020 03:05AM
|
|
Re: The problem...as I see it
|
4
|
Resverlogix Corp.
|
Oct 21, 2020 03:45AM
|
|
Re: Tax strategy question for Canadian!
|
3
|
Resverlogix Corp.
|
Oct 25, 2020 02:03PM
|
|
Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
|
2
|
Resverlogix Corp.
|
Oct 26, 2020 08:55PM
|
|
Re: Option #2 and Option #3 questions
|
3
|
Resverlogix Corp.
|
Oct 27, 2020 02:33PM
|
|
Re: Option #2 and Option #3 questions
|
1
|
Resverlogix Corp.
|
Oct 27, 2020 03:04PM
|
|
Re: Option #2 and Option #3 questions
|
2
|
Resverlogix Corp.
|
Oct 27, 2020 04:40PM
|
|
Re: Option #2 and Option #3 questions
|
1
|
Resverlogix Corp.
|
Oct 27, 2020 07:17PM
|
|
Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
|
5
|
Resverlogix Corp.
|
Nov 02, 2020 12:50PM
|
|
Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
|
6
|
Resverlogix Corp.
|
Nov 02, 2020 01:14PM
|
